High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
Authors:
- D G EvansD G Evans
- M E BaserMBM E Baser
- J Zucman-RossiJZJ Zucman-Rossi
- M HergersbergMHM Hergersberg
Open Access
- 1 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 10 (3) , 271-282
Abstract
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder whose hallmark is bilateral vestibular schwannoma. It displays a pronounced clinical heterogeneity with mild to severe forms. The NF2 tumor suppressor (merlin/schwannomin) has been cloned and extensively analyzed for mutations in patients with different clinical variants of the disease. Correlation between the type of the NF2 gene mutation and the patient phenotype has been suggested to exist. However, several independent studies have shown that a fraction of NF2 patients with various phenotypes have constitutional deletions that partly or entirely remove one copy of the NF2 gene. The purpose of this study was to examine a 7 Mb interval in the vicinity of the NF2 gene in a large series of NF2 patients in order to determine the frequency and extent of deletions. A total of 116 NF2 patients were analyzed using high-resolution array-comparative genomic hybridization (CGH) on an array covering at least 90% of this region of 22q around the NF2 locus. Deletions, which remove one copy of the entire gene or are predicted to truncate the schwannomin protein, were detected in 8 severe, 10 moderate and 6 mild patients. This result does not support the correlation between the type of mutation affecting the NF2 gene and the disease phenotype. This work also demonstrates the general usefulness of the array-CGH methodology for rapid and comprehensive detection of small (down to 40 kb) heterozygous and/or homozygous deletions occurring in constitutional or tumor-derived DNA.Keywords
This publication has 25 references indexed in Scilit:
- Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNature Genetics, 2000
- Fine mapping of the constitutional translocation t(11;22)(q23;q11)Human Genetics, 2000
- High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 1998
- Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalancesGenes, Chromosomes and Cancer, 1997
- The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2JAMA, 1997
- Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesHuman Genetics, 1996
- A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2Human Genetics, 1996
- Fifty probands with extra structurally abnormal chromosomes characterized by fluorescence in situ hybridizationAmerican Journal of Medical Genetics, 1995
- Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneityAmerican Journal of Medical Genetics, 1994
- Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2Nature, 1993